KC706 Completed Phase 2 Trials for Pemphigus Vulgaris (PV) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00606749Use of KC706 for the Treatment of Pemphigus Vulgaris